The reduction of diaryldiselenides by Cp2TiCl2/BuiMgBr/THF led to arylselenium complex of titanocene [Cp2TiSeAr]. This species reacted smoothly with electrophilic substrates such as acylhalides, α-bromocarbonyl compo...The reduction of diaryldiselenides by Cp2TiCl2/BuiMgBr/THF led to arylselenium complex of titanocene [Cp2TiSeAr]. This species reacted smoothly with electrophilic substrates such as acylhalides, α-bromocarbonyl compounds, diaryliodonium salts, α,β-unsaturated carbonyl compounds to afford the corresponding organic selenides in high yields.展开更多
文摘目的:检测新型有机硒化合物双硒唑烷-1(Ethaselen-1,Eb1)的动物体内免疫调节作用。方法:建立Lew-is肺癌(Lew is lung cancer,LLC)皮下移植瘤C57/BL鼠动物模型,选取25.0 mg/kg和12.5 mg/kg两个剂量的Eb1作为实验药物,以左旋咪唑(levam isole,LMS)2.0 mg/kg作为阳性对照,以溶剂5 g/L羧甲基纤维素钠溶液为阴性对照,于接种肿瘤后第2天开始向C57/BL鼠腹腔连续注射7 d药物,探讨Eb1对正常及肿瘤鼠的相对脾重、脾淋巴细胞转化活性、自然杀伤(natural k iller,NK)细胞活性、淋巴因子-激活杀伤(lymphok ine-activated k iller,LAK)细胞活性及淋巴细胞CD4+,CD8+亚群阳性细胞百分数的影响。结果:高剂量Eb1能够使正常鼠和肿瘤鼠的相对脾重增加150.59%和122.55%,脾淋巴细胞转化活性增加162.25%和561.98%,NK细胞活性增加78.60%和219.42%,脾淋巴细胞CD4-CD8+亚群阳性细胞百分含量增加104.72%和105.87%,高剂量Eb1亦能使肿瘤鼠的LAK细胞活性增加195.11%,与对照组相比差异均有统计学意义(P<0.01)。结论:新型有机硒化合物Eb1在C57/BL小鼠体内具有明显的免疫调节作用。
文摘The reduction of diaryldiselenides by Cp2TiCl2/BuiMgBr/THF led to arylselenium complex of titanocene [Cp2TiSeAr]. This species reacted smoothly with electrophilic substrates such as acylhalides, α-bromocarbonyl compounds, diaryliodonium salts, α,β-unsaturated carbonyl compounds to afford the corresponding organic selenides in high yields.
